Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DER 45 EV Gel in rosacea
NCT00940992Phase 2Completed
- Sponsor
- Sol-Gel Technologies
- Start
- Jan 2012
- Primary completion
- Sep 2012
- Countries
- 1
01
Overview
A Phase 2 trial of zilxi in rosacea, sponsored by Sol-Gel Technologies. Started Jan 2012; status: completed.
02
Drugs
zilxi
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT00940992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940992.